Я ненавижу тебя, только не бросай меня. Пограничные личности и как их понять

Controlled Pilot Study,” American Journal of Psychiatry 160 (2003): 167–169.

152

Christopher Pittenger, John H. Krystal, and Vladimir Coric, “Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self- Injurious Behavior Associated with Borderline Personality Disorder” (Letter to the Editor), Journal of Clinical Psychiatry 66 (2005): 1492– 1493.

153

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Revised, 3rd ed. (DSM-III-R) (Washington, DC: American Psychiatric Association, 1987): 16.

154

Michael H. Stone, The Fate of Borderline Patients: Successful Outcome and Psychiatric Practice (New York: Guilford, 1990).

155

Mary C. Zanarini, Frances R. Frankenburg, John Hennen, et al., “The McLean Study of Adult Development (MSAD): Overview and Implications of the First Six Years of Prospective Follow-Up,” Journal of Personality Disorders 19 (2005): 505–523.

156

Andrew E. Skodol, John G. Gunderson, M. Tracie Shea, et al., “The Collaborative Longitudinal Personality Disorders Study: Overview and Implications,” Journal of Personality Disorders 19 (2005): 487–504.

157

Andrew Morton, Diana: Her New Life (Philadelphia: Trans-Atlantic Publications, 1995): 155.

158

Michael H. Stone, “The Borderline Syndrome: Evolution of the Term, Genetic Aspects and Prognosis,” American Journal of Psychotherapy 31 (1977): 345–365.